In the news | 9th May 2022
A legacy system approach isn’t suitable for modern BioPharma development. Here are four reasons why.
Modern BioPharma development requires more than just a LIMS and spreadsheets. Learn why in this article by Alberto Pascual, IDBS, featuring Accenture and published in Lab Manager.
A new blueprint for technology transfer
Technology transfer is a necessary evil that exists between drug development and manufacturing. But information sharing is disjointed.
Tradeshow | Paperless Lab Academy 2023 India, October 10-11, 2023
Come and see us at Paperless Lab Academy 2023 India. Visit our booth G8 and attend our workshop on “Managing R&D data for faster and efficient workflows with IDBS Polar platform”.
Tradeshow | Festival of Biologics | October 2023
Come and see us at Festival of Biologics in Basel. Visit our booth 604 and hear Marc Smith, Director of Strategic Solutions, speak.
Tradeshow | Biologics Contract Manufacturing Asia | September, 2023
Learn how to overcome manufacturing data challenges with IDBS at this year’s event in Singapore. We look forward to seeing you there!